Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
0.7831
+0.1631 (26.31%)
Aug 15, 2025, 3:06 PM EDT
Vaccinex Market Cap
Vaccinex has a market cap or net worth of $2.10 million as of August 15, 2025. Its market cap has decreased by -79.71% in one year.
Market Cap
2.10M
Enterprise Value
2.68M
Revenue
601.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.78
Market Cap Chart
Since August 9, 2018, Vaccinex's market cap has decreased from 130.58M to 2.10M, a decrease of -98.39%. That is a compound annual growth rate of -44.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 2.10M | -20.09% |
| Dec 31, 2024 | 2.62M | -68.42% |
| Dec 29, 2023 | 8.31M | -74.16% |
| Dec 30, 2022 | 32.15M | 0.35% |
| Dec 31, 2021 | 32.03M | -30.87% |
| Dec 31, 2020 | 46.34M | -35.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.89M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 362.70M |
| CytoDyn | 344.75M |